Location: Redwood City, CA
CIK: 0002055980 · Show all filings
Period: Q3 2026 (← Previous)
Filing Date: Oct 15, 2026
Total Value: $117M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| BCAX | BICARA THERAPEUTICS INC | 2,920,509 (-7.7%) | $54.35M (-42.1%) | 46.6% | $18.61 | $20.81 | -10.6% | COM | 055477103 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| CBLL | CERIBELL INC | 2,205,661 | $53.8M | 46.1% | $24.39 | $27.25 | -10.5% | COM | 15678C102 |
| CTNM | CONTINEUM THERAPEUTICS INC | 638,158 | $8.564M | 7.3% | $13.42 | $15.84 | -15.3% | CL A | 21217B100 |